Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01813214
Title The Effects of Vemurafenib on Immunity in Patients With Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Georgetown University
Indications

melanoma

Therapies

Vemurafenib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST